Personalis News - PSNL

Company Name	Stock Ticker Symbol	Market	Type
Personalis Inc	PSNL	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.015	1.20%	1.265	12:14:08

Open Price	Low Price	High Price	Close Price	Prev Close
1.25	1.24	1.275		1.25

more quote information »

Recent News

Date	Time	Source	Heading
4/24/2024	16:01	BW	Personalis to Announce First Quarter 2024 Financial Results
3/28/2024	16:01	BW	Personalis to Present at the 23rd Annual Needham Virtual..
3/28/2024	09:00	BW	Data Showcasing NeXT Personal MRD Test to be Presented at..
3/26/2024	09:00	BW	Personalis Announces Publication Validating NeXT Personal®..
3/19/2024	16:43	BW	Personalis Announces Inducement Grants Under Nasdaq Listing..
2/28/2024	16:01	BW	Personalis Reports Fourth Quarter and Full Year 2023..
2/28/2024	16:00	EDGAR2	Form 8-K - Current report
2/14/2024	16:01	BW	Personalis to Announce Fourth Quarter and Full Year 2023..
1/31/2024	16:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/31/2024	16:01	BW	Personalis to Participate at Upcoming Investor Conferences
1/30/2024	09:00	BW	Personalis and ClearNote Health Announce Partnership to..
1/29/2024	16:00	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
1/17/2024	16:15	BW	Personalis Announces Inducement Grants Under Nasdaq Listing..
1/16/2024	09:05	BW	Personalis Announces Medicare Coverage for NeXT Dx(R)..
1/10/2024	00:15	EDGAR2	Form EFFECT - Notice of Effectiveness
1/05/2024	09:09	EDGAR2	Form 8-K - Current report
1/05/2024	09:05	BW	Personalis Reports Preliminary Fourth Quarter and Full Year..
12/21/2023	17:15	EDGAR2	Form S-3 - Registration statement under Securities Act of..
12/21/2023	17:12	EDGAR2	Form S-3 - Registration statement under Securities Act of..
12/19/2023	18:09	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/19/2023	18:02	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/05/2023	16:05	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
12/04/2023	09:15	BW	Personalis Extends Cash Position Into 2026, Provides Update..
12/01/2023	16:51	EDGAR2	Form 8-K - Current report
11/28/2023	16:58	EDGAR2	Form 8-K - Current report
11/28/2023	16:15	BW	Personalis and Tempus Enter into a Strategic Collaboration..
11/20/2023	16:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/20/2023	16:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/07/2023	16:11	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/07/2023	16:01	BW	Personalis Reports Third Quarter 2023 Financial Results
11/07/2023	16:00	EDGAR2	Form 8-K - Current report
10/26/2023	08:15	BW	Personalis Launches NeXT Personal® Dx for Early Access..
10/24/2023	16:01	BW	Personalis to Announce Third Quarter 2023 Financial Results
10/21/2023	04:25	BW	Analysis from TRACERx Study Reveals More Sensitive and..
10/19/2023	07:15	BW	Personalis Announces Late-Breaking NeXT Personal Abstract..
10/18/2023	07:15	BW	Personalis Appoints Former Roche Diagnostics and GRAIL..
8/29/2023	16:01	BW	Personalis to Present at the 21st Annual Morgan Stanley..
8/28/2023	17:11	EDGAR2	Form 8-K - Current report
8/24/2023	19:01	BW	Personalis Announces Inducement Grants Under Nasdaq Listing..
8/08/2023	16:08	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/08/2023	16:01	EDGAR2	Form 8-K - Current report
8/08/2023	16:01	BW	Personalis Reports Second Quarter 2023 Financial Results
8/02/2023	16:20	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/01/2023	16:01	BW	Personalis to Participate at Upcoming Investor Conferences
7/25/2023	16:01	BW	Personalis to Announce Second Quarter 2023 Financial Results
6/26/2023	17:00	BW	Personalis Files Second Patent Infringement Suit Against..
6/13/2023	19:01	BW	Dr. Kenneth J. Widder Joins Personalis Board of Directors
5/30/2023	08:00	BW	Personalis Announces Two Abstracts Accepted for Presentation..
5/16/2023	16:19	BW	Personalis、国立がん研究センター東病院、小野薬品が提携、直腸がん免疫療法反応の予測向上へ
5/16/2023	08:00	BW	Personalis, National Cancer Center Hospital East, and Ono..